Common IBS and Digestive Medications: Long-Term Health Risks and Warnings

Irritable bowel syndrome (IBS) affects an estimated 10–15% of the global population, making it one of the most common functional gastrointestinal disorders worldwide. Characterized by recurring abdominal pain, bloating, and altered bowel habits—ranging from diarrhea-predominant (IBS-D) to constipation-predominant (IBS-C) or mixed types (IBS-M)—IBS significantly impacts quality of life, often leading to anxiety, social withdrawal, and … Read more